Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOOD-HF trial of escitalopram in depressed patients with chronic heart failure
ISRCTN33128015Phase 4Completed
- Sponsor
- Bundesministerium für Bildung und Forschung
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) and heart failure (HF) comparing Escitalopram + nurse support + cardiological care with Placebo + nurse support + cardiological care (2 arms). Primary endpoint: Time to first event of death or hospitalisation. Started Aug 2007; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)heart failure (HF)
Beyond the preview
Go deeper on ISRCTN33128015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN33128015.